Discover 250 paid clinical trials in Spokane, Washington. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 250
Testing the Addition of Immunotherapy Before Surgery for Patients With Sarcomatoid Mesothelioma
Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
for
High-Risk Non-Muscle-Invasive Bladder Cancer
Location: Spokane WA, Portland OR, Springfield OR, Sacramento CA,
Sponsor: CG Oncology, Inc.
Sex: All
Age: 18+
Code: NCT06567743
Phase 2, Recruiting
A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer
for
Non-Muscle Invasive Bladder Cancer
Location: Spokane WA, Lakewood CO, Aurora CO, Los Angeles CA,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT06319820
Phase 3, Recruiting
Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer
for
Intermediate Risk Non-Muscle Invasive Bladder Cancer
Location: Spokane WA, Calgary, Portland OR, Fresno CA, Denver CO,
Sponsor: Ferring Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06510374
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study to Assess Real-World Use and Outcomes of TAR-200 for Participants With Non-Muscle Invasive Bladder Cancer (NMIBC) in the United States
for
Non-Muscle Invasive Bladder Neoplasms
Location: Spokane WA, Seattle WA, Lakewood CO, Los Angeles CA,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT07309445
Recruiting
Metastatic Castrate-Resistant Prostate Cancer Subjects Treated With PROVENGE® + One Infusion of Sipuleucel-T
for
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Location: Spokane WA, Springfield OR, Fresno CA, Lakewood CO,
Sponsor: Dendreon
Sex: Male
Age: 18+
Code: NCT06134232
Phase 2, Recruiting
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
for
Metastatic Castration-resistant Prostate Cancer (mCRPC),
Location: Spokane WA, Abbotsford British Columbia, Billings MT,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06136650
Phase 3, Recruiting
New
A Study Evaluating TRIV-573 in Atopic Dermatitis
for
Atopic Dermatitis
Location: Spokane WA, Calgary, Los Angeles CA, Fountain Valley CA,
Sponsor: Triveni Bio
Sex: All
Age: 18 - 70+
Code: NCT07782333
Phase 2, Recruiting
Open Label Study to Investigate the Safety and Efficacy of Ponesimod in Moderate-to-Severe Chronic Plaque Psoriasis
for
Moderate-to-severe Chronic Plaque Psoriasis
Location: Spokane WA, Fremont CA, Glendale AZ, San Antonio TX,
Sponsor: Vanda Pharmaceuticals
Sex: All
Age: 18 - 65
Code: NCT07362017
Phase 3, Recruiting
A Study to Evaluate the Efficacy, Safety and Tolerability of ALKS 2680 in Adults With Narcolepsy Type 1 (Brilliance NT1 - 304)
for
Narcolepsy Type 1
Location: Spokane WA, Scottsdale AZ, Rochester MN, El Paso TX,
Sponsor: Alkermes, Inc.
Sex: All
Age: 18 - 70
Code: NCT07540897
Phase 3, Recruiting
A Study to Evaluate the Efficacy, Safety, and Tolerability of VIM0423 in Individuals With Isolated Dystonia
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)
for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
A Phase 1 of CTX-8371 in Patients With Advanced Malignancies
for
Non Small Cell Lung Cancer, Triple Negative Breast Cancer,
Location: Spokane WA, Palo Alto CA, Fort Wayne IN, Nashville TN,
Sponsor: Compass Therapeutics
Sex: All
Age: 18+
Code: NCT06150664
Phase 1, Recruiting
A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
for
Triple Negative Breast Cancer, Breast Cancer,
Location: Spokane WA, Seattle WA, Salt Lake City UT,
Sponsor: Day One Biopharmaceuticals, Inc.
Sex: All
Age: 18+
Code: NCT05377996
Phase 1, Phase 2, Recruiting
A Study of TTI-101 as Monotherapy and in Combination in Participants With Locally Advanced or Metastatic, and Unresectable Hepatocellular Carcinoma
for
Hepatocellular Carcinoma
Location: Spokane WA, Seattle WA, Aurora CO, Los Angeles CA,
Sponsor: Tvardi Therapeutics, Incorporated
Sex: All
Age: 18+
Code: NCT05440708
Phase 1, Phase 2, Recruiting
A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)